Predictors of achieving HbA 1c <7% and no hypoglycaemia 6 months after initiation of biphasic insulin aspart 30 in patients with type 2 diabetes in the IMPROVE study

By Valensi Paul  

Current Medical Research and Opinion, Vol. 29, Iss. 6, 2013-06 ,pp. : 601-609

Informa Healthcare

Access to resources Recommend Favorite

Assessment of quality of life in patients with type 2 diabetes mellitus before and after starting biphasic insulin aspart 30 (BIAsp 30) therapy: IMPROVE study in Japan

By Ishii Hitoshi   Iwase Masanori   Seino Hiroaki   Shuto Yujin   Atsumi Yoshihito  

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 643-650

Informa Healthcare

Access to resources Recommend Favorite

Transferring type 2 diabetes patients with uncontrolled glycaemia from biphasic human insulin to biphasic insulin aspart 30: experiences from the PRESENT study

By Shestakova M.   Sharma S. K.   Almustafa M.   Min K. W.   Ayad N.   Azar S. T.   Danciulescu R.   Khutsoane D.   Guler S.  

Current Medical Research and Opinion, Vol. 23, Iss. 12, 2007-12 ,pp. : 3209-3214

Informa Healthcare

Access to resources Recommend Favorite

Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT

By Strojek Krzysztof   Bebakar Wan M.W.   Khutsoane Duma T.   Pesic Milica   Šmahelová Alena   Thomsen Henrik F.   Kalra Sanjay  

Current Medical Research and Opinion, Vol. 25, Iss. 12, 2009-12 ,pp. : 2887-2894

Informa Healthcare

Access to resources Recommend Favorite

Treat-to-target comparison between once daily biphasic insulin aspart 30 and insulin glargine in Chinese and Japanese insulin-naïve subjects with type 2 diabetes

By Yang Wenying   Xu Xiangjin   Liu Xiaomin   Yang Gangyi   Seino Yutaka   Andersen Henning   Jinnouchi Hideaki  

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1599-1608

Informa Healthcare

Access to resources Recommend Favorite